Management of melanoma

Pippa Corrie1, Mirela Hategan2, Kate Fife2

  • 1Cambridge Cancer Centre, Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital), Cambridge CB2 0QQ, UK pippa.corrie@addenbrookes.nhs.uk.

British Medical Bulletin
|September 6, 2014
PubMed
Abstract

Insights

Early diagnosis and integrated management are crucial for melanoma patients, especially with rising global incidence. Advances in systemic therapies like targeted agents and immunotherapies offer survival gains, necessitating proactive multidisciplinary care.

Area of Science:

  • Oncology
  • Dermatology
  • Cancer Biology

Background:

  • Melanoma is a curable cancer, but 20% of patients develop advanced disease.
  • Rising global incidence necessitates improved management strategies.

Purpose of the Study:

  • To review current understanding and management of melanoma.
  • To highlight the need for integrated, multidisciplinary approaches.

Main Methods:

  • Literature review of PubMed references on melanoma research and treatment.

Main Results:

  • Melanoma incidence is rapidly increasing worldwide.
  • Effective treatments include surgery, molecular targeted therapies, and immunotherapies.
  • Early diagnosis and multidisciplinary interventions are essential.

Conclusions:

  • Molecular factors increasingly guide melanoma treatment decisions.
  • Screening, surveillance, and patient education are vital for improved outcomes.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K